Corpus overview


Overview

MeSH Disease

Human Phenotype

Pneumonia (1)


Transmission

There are no transmission terms in the subcorpus


Seroprevalence
    displaying 1 - 1 records in total 1
    records per page




    COVID-19: Beta-Thalassemia Subjects Immunised?

    Authors: Edouard Lansiaux; Philippe Pierre Pebay; Jean Laurent Picard; Joachim Son-Forget

    id:10.20944/preprints202004.0349.v1 Date: 2020-04-19 Source: Preprints.org

    The novel coronavirus pneumonia MESHD pneumonia HP (COVID-19) is a contagious acute respiratory infectious disease MESHD whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent pre-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia MESHD results of a default in the hemoglobin beta- chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection MESHD in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences SERO, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence SERO is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research .

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.